title: Transforming growth factor-β1-mediated cardiac fibrosis: potential role in HIV and HIV/antiretroviral therapy-linked cardiovascular disease.
authors.affiliation: aDivision of Hematology and Medical OncologybDivision of Nephrology and Hypertension, Weill Cornell Medical College, New YorkcCardiovascular Biology Research Program, Oklahoma Medical Research Foundation and Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
authors.forename: Jasimuddin
authors.initials: J
authors.lastname: Ahamed
authors.forename: Hunter
authors.initials: H
authors.lastname: Terry
authors.forename: Mary E
authors.initials: ME
authors.lastname: Choi
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Laurence
mesh_terms: D000818:Animals; D044966:Anti-Retroviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000473:pathology*; D004195:Disease Models, Animal; D005355:Fibrosis / Q000139:chemically induced* / Q000473:pathology*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D051379:Mice; D053773:Transforming Growth Factor beta1 / Q000378:metabolism*
chemical_list: D044966:Anti-Retroviral Agents; D053773:Transforming Growth Factor beta1